Drugs / Cephazolin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04079686 | Aug 2019 → Oct 2024 | skin infection | Daniela Francescato Veiga | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT01235546 Comparator | May 2011 → Dec 2015 | abscess, endometritis, skin infection | Alan Tita | Completed | Met primary |
| — | NCT02077400 Comparator | Jan 2006 → Feb 2015 | — | HaEmek Medical Center, Israel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cephazolin | “standard of care (cephazolin or clindamycin)” NCT01235546 ↗ |
| Route | Intravenous | “receive antibiotics (1g cephazolin) intravenously” NCT04079686 ↗ |